EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES

Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Hovedforfatter: A. N. Meshkov
Format: Artigo
Sprog:Inglês
Udgivet: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Serier:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Fag:
hypercholesterolemia
ischemic heart disease
atorvastatin
Online adgang:https://www.rpcardio.com/jour/article/view/820
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker